InsidersTradesSigma
サンバイオ株式会社 Stock: price and management transactions · Japan · EDINET (Japan FSA)
Follow the サンバイオ株式会社 stock price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares are quoted on JP JP, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, サンバイオ株式会社 has published 19 public disclosures. Market capitalisation: €80.8bn. The latest transaction was filed on 22 July 2026 (Holding update). Among the most active insiders: Nomura Securities Co.,Ltd.. The full history is free.
19
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate サンバイオ株式会社 Hold (neutral), based on 5 analysts. Average price target: JP¥1,580.
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 22 July 2026
Declarations19 total
ShareXTKSEDINET:S100YRFF
ShareXTKSEDINET:S100YI78
ShareXTKSEDINET:S100YCFN
ShareXTKSEDINET:S100XWQJ
ShareXTKSEDINET:S100X8FZ
ShareXTKSEDINET:S100X7GJ
ShareXTKSEDINET:S100X579
ShareXTKSEDINET:S100X2HB
ShareXTKSEDINET:S100X2QF
ShareXTKSEDINET:S100VSLK
ShareXTKSEDINET:S100SKU6
ShareXTKSEDINET:S100RJS9
ShareXTKSEDINET:S100QK07
ShareXTKSEDINET:S100Q9Z8
ShareXTKSEDINET:S100Q36O
ShareXTKSEDINET:S100Q2S9
30.1% of flowShareXTKSEDINET:S100PX3N
33.2% of flowShareXTKSEDINET:S100PVVV
36.6% of flowShareXTKSEDINET:S100PS2P
19 of 19 declarations
About サンバイオ株式会社
SanBio Company is a company focused on the health and pharmaceutical sector, dedicated to developing innovative therapies. It is listed on the XTKS market.